Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.37 million shares were traded. GDRX stock price reached its highest trading level at $4.79 during the session, while it also had its lowest trading level at $4.575.
Ratios:
We take a closer look at GDRX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.75. For the most recent quarter (mrq), Quick Ratio is recorded 5.32 and its Current Ratio is at 5.32. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.74.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 04, 2024, initiated with a Neutral rating and assigned the stock a target price of $5.
On August 09, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $10.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on May 23, 2024, whereas the target price for the stock was revised from $8 to $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 02 ’24 when Bradley Julie MB bought 95,255 shares for $4.95 per share.
Spectrum Equity VII, L.P. sold 10,677 shares of GDRX for $83,922 on Sep 03 ’24. The 10% Owner now owns 0 shares after completing the transaction at $7.86 per share. On Sep 03 ’24, another insider, Spectrum VII Investment Manage, who serves as the Affiliate of the company, bought 6,828 shares for $7.86 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GDRX now has a Market Capitalization of 1779950336 and an Enterprise Value of 1874989824. As of this moment, GoodRx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 108.92, and their Forward P/E ratio for the next fiscal year is 9.93. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.70. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.25 while its Price-to-Book (P/B) ratio in mrq is 2.45. Its current Enterprise Value per Revenue stands at 2.366 whereas that against EBITDA is 18.836.
Stock Price History:
The Beta on a monthly basis for GDRX is 1.24, which has changed by -0.34277618 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, GDRX has reached a high of $9.26, while it has fallen to a 52-week low of $4.09. The 50-Day Moving Average of the stock is -2.05%, while the 200-Day Moving Average is calculated to be -25.99%.
Shares Statistics:
According to the various share statistics, GDRX traded on average about 1.44M shares per day over the past 3-months and 1818830 shares per day over the past 10 days. A total of 105.95M shares are outstanding, with a floating share count of 88.88M. Insiders hold about 76.83% of the company’s shares, while institutions hold 16.15% stake in the company. Shares short for GDRX as of 1740700800 were 6355042 with a Short Ratio of 4.42, compared to 1738281600 on 6684259. Therefore, it implies a Short% of Shares Outstanding of 6355042 and a Short% of Float of 6.6300004999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
